目前位置: 財報狗 / 首頁 / 藥品 / 藥品概念股負債和股東權益排名

藥品概念股負債和股東權益排名

藥品概念股最新負債和股東權益。點擊股票可查詢歷史數據趨勢。

查看更多標籤
股號 / 名稱 總負債 淨值
TAK Takeda Pharmaceutical Co Ltd 1,555,272,894,282.7 1,530,662,354,921.58
NVS Novartis 2,034,699,937,313.41 1,448,043,137,170.7
LLY 禮來公司 2,697,729,790,842.99 832,946,556,358.65
GSK 葛蘭素史克 1,889,732,554,414.21 691,717,888,371.77
LH Labcorp Holdings Inc 306,776,084,440.83 270,579,714,584.52
UTHR United Therapeutics Corp 24,603,863,232.48 222,753,169,520.72
GRFS Grifols SA 540,609,355,757.71 190,788,470,984.69
JAZZ Jazz Pharmaceuticals PLC 232,209,710,498.14 124,275,877,332.6
ZTS 碩騰 380,954,942,829.04 104,561,710,165.09
NBIX Neurocrine Biosciences Inc 43,268,646,439.98 102,116,391,275.31
STVN Stevanato Group SpA 35,983,176,595.38 52,947,023,579.78
CRNX Crinetics Pharmaceuticals Inc 3,888,088,425.24 33,655,906,402.28
RXRX Recursion Pharmaceuticals Inc 11,067,594,910.41 32,864,206,945.04
INVA Innoviva Inc 13,157,479,322.8 31,702,853,120.07
CPRX Catalyst Pharmaceuticals Inc 4,123,360,120.73 28,886,938,147.97
SNDL SNDL Inc 4,935,182,778.87 24,798,656,178.5
AMPH Amphastar Pharmaceuticals Inc 27,921,084,272.23 24,382,434,741.49
PCRX Pacira Biosciences Inc 17,903,971,988.86 22,827,601,169.62
DYN Dyne Therapeutics Inc 5,501,998,892.49 21,715,404,846.33
SMMT Summit Therapeutics Inc 2,898,032,484.5 20,681,935,862.92
OCUL Ocular Therapeutix Inc 4,826,193,111.0 20,539,109,149.84
CORT Corcept Therapeutics Inc 5,927,967,792.81 20,334,914,035.87
XNCR Xencor Inc 7,530,828,808.85 19,951,385,073.16
RLAY Relay Therapeutics Inc 1,955,344,787.72 19,076,281,093.58
MDGL Madrigal Pharmaceuticals Inc 20,620,410,509.59 18,918,700,851.9
ARWR Arrowhead Pharmaceuticals Inc 32,512,978,792.82 17,843,043,054.78
USNA USANA Health Sciences Inc 6,586,069,339.97 16,734,393,856.45
IONS Ionis Pharmaceuticals Inc 95,270,126,193.65 15,349,947,844.71
SLNO Soleno Therapeutics Inc 3,569,569,159.84 14,129,328,781.43
ORGO Organogenesis Holdings Inc 3,887,648,958.43 12,116,068,546.33
AUPH Aurinia Pharmaceuticals Inc 5,077,630,906.99 11,481,729,597.36
LYEL Lyell Immunopharma Inc 2,474,951,508.93 10,331,268,271.16
CNTA Centessa Pharmaceuticals PLC 4,605,800,506.06 9,466,554,542.58
1720 生達 2,509,094,000 9,286,809,000
COLL Collegium Pharmaceutical Inc 41,828,450,924.4 8,626,356,783.86
BLUW Blue Water Acquisition Corp III 287,122,814.82 7,786,316,291.49
TBPH Theravance Biopharma Inc 5,737,521,711.88 7,303,969,763.71
TNXP Tonix Pharmaceuticals Holding Corp 668,523,188.65 7,255,691,195.64
SIGA SIGA Technologies Inc 882,832,317.33 6,387,301,013.29
IPSC Century Therapeutics Inc 2,146,136,164.0 5,535,649,493.9
ARDX Ardelyx Inc 10,504,983,222.85 5,240,610,312.32
NATR Nature's Sunshine Products Inc 3,274,121,901.94 5,038,235,846.57
LRMR Larimar Therapeutics Inc 1,516,537,178.47 4,364,470,446.69
TARA Protara Therapeutics Inc 387,515,554.48 4,152,678,835.02
ENTA Enanta Pharmaceuticals Inc 6,369,506,374.37 3,973,753,062.6
PMVP PMV Pharmaceuticals Inc 403,210,797.68 3,798,217,462.7
RIGL Rigel Pharmaceuticals Inc 3,921,456,512.27 3,691,803,713.84
NOTV Inotiv Inc 19,628,847,825.5 3,422,316,388.18
ASRT Assertio Holdings Inc 6,716,685,153.84 3,321,207,631.52
SVRA Savara Inc 1,460,850,455.62 2,962,822,448.41
CRBP Corbus Pharmaceuticals Holdings Inc 545,158,577.14 2,892,539,149.38
AVTX Avalo Therapeutics Inc 1,053,244,989.84 2,873,704,857.55
RFL Rafael Holdings Inc 633,899,482.16 2,673,873,021.19
NKTR Nektar Therapeutics 6,788,537,977.19 2,670,890,924.98
SAVA Cassava Sciences Inc 1,511,922,776.97 2,560,459,193.86
CTXR Citius Pharmaceuticals Inc 1,897,039,156.58 2,509,925,533.25
SLN Silence Therapeutics PLC 2,282,935,903.69 2,324,873,593.5
IXHL Incannex Healthcare Inc 50,224,778.22 2,304,250,043.94
CNTX Context Therapeutics Inc 190,131,862.16 2,296,972,787.48
IKT Inhibikase Therapeutics Inc 210,198,230.58 2,288,313,094.0
PYXS Pyxis Oncology Inc 1,155,954,661.31 2,159,006,263.42
NAII Natural Alternatives International Inc 2,707,586,403.57 2,104,606,550.5
PRLD Prelude Therapeutics Inc 1,136,994,807.53 1,837,410,730.35
UPC Universe Pharmaceuticals Inc 413,536,070.37 1,761,932,619.73
MDWD Mediwound Ltd 1,389,562,661.03 1,574,421,235.38
AKBA Akebia Therapeutics Inc 10,125,315,289.96 1,305,593,109.93
UNCY Unicycive Therapeutics Inc 412,188,476.79 1,176,515,429.9
PMCB PharmaCyte Biotech Inc 609,677,955.05 1,147,450,664.64
SCYX SCYNEXIS Inc 459,588,111.24 1,143,555,419.19
ACHV Achieve Life Sciences Inc 578,369,711.74 1,055,191,200.0
VYNE Vyne Therapeutics Inc 126,943,126.96 1,007,257,927.28
TXMD TherapeuticsMD Inc 352,420,990.7 861,480,508.49
CPIX Cumberland Pharmaceuticals Inc 1,248,673,054.87 819,914,795.93
DERM Journey Medical Corp 1,861,236,109.52 812,950,816.53
COSM Cosmos Health Inc 1,455,196,087.3 726,215,135.77
KPRX Kiora Pharmaceuticals Inc 233,944,191.82 703,484,028.96
SXTC China SXT Pharmaceuticals Inc 192,101,929.09 635,140,348.09
BLRX BioLine RX Ltd 636,316,549.61 613,150,370.66
GLMD Galmed Pharmaceuticals Ltd 77,597,282.36 599,934,975.89
MRKR Marker Therapeutics Inc 105,030,684.03 577,236,201.27
ENLV Enlivex Ltd 108,516,911.45 548,737,092.58
HRTX Heron Therapeutics Inc 7,347,414,196.88 467,247,389.92
LPCN Lipocine Inc 60,618,796.08 443,925,828.05
ATNM Actinium Pharmaceuticals Inc 1,329,920,736.89 432,686,464.4
NNVC NanoViricides, Inc 37,540,824.39 347,546,675.97
PYPD PolyPid Ltd 355,779,772.74 344,447,807.16
PHIO Phio Pharmaceuticals Corp 52,296,550.33 308,850,995.59
INM InMed Pharmaceuticals Inc 50,344,689.88 300,961,310.74
RLMD Relmada Therapeutics Inc 169,844,818.62 297,127,904.54
IGC IGC Pharma Inc 51,825,693.03 254,011,815.87
NTRB Nutriband Inc 27,316,315.16 236,965,212.23
ADXN Addex Therapeutics Ltd 54,111,562.37 234,962,281.73
MTEX Mannatech Inc 846,601,417.94 218,163,880.41
MTNB Matinas BioPharma Holdings Inc 101,548,223.47 202,782,542.08
TPST Tempest Therapeutics Inc 338,483,614.74 199,204,026.63
GANX Gain Therapeutics Inc 158,906,489.73 185,499,881.99
PCSA Processa Pharmaceuticals Inc 54,964,113.86 183,119,541.4
JAGX Jaguar Health Inc 1,376,315,875.77 176,634,266.92
PSTV Plus Therapeutics Inc 427,412,862.69 158,647,518.22
INDP Indaptus Therapeutics Inc 70,136,705.46 144,576,104.88

最新要聞